The Biomarker Core at the UCI Alzheimer’s Disease Research Center (ADRC), led by Dr. Craig Stark, accelerates our efforts to identify early and presymptomatic stages of Alzheimer’s disease (AD) and related dementias using biomarkers (or biological markers), such as brain imaging techniques and biofluid analyses.
Researchers have made strong progress with brain imaging and fluid biomarkers in the diagnosis of AD and Mild Cognitive Impairment, but there is still much to be done to identify, quantify, and validate factors that influence the risk of AD across the lifespan. The Biomarker Core plays a key role in this effort by assisting in the data collection and processing of both traditional, established biomarkers and development of novel biomarkers.
The Biomarker Core at the UCI ADRC provides state-of-the-art biomarker data and analyses. The new Facility for Imaging and Brain Research (FIBRE) operated by Dr. Stark is equipped with ideal instruments for ADRC biomarker analysis. In addition, the Core will assist researchers with innovative biomarker studies aiming to determine disease etiology, measure disease progression, and assess treatment effectiveness.
- Craig Stark, PhD, Core Leader